- Significant unmet need for new effective therapies exists in ulcerative colitis - ELEVATE UC clinical trial sites continue to initiate SAN DIEGO, June 17, 2019 /PRNewswire/ -- Arena Pharmaceuticals, ...
– Significant unmet need for safe and effective oral therapies in UC for patients with inadequate response, loss of response or intolerance to conventional or advanced therapies SAN DIEGO--(BUSINESS ...
- Significant unmet need for new and effective oral therapies in UC for patients with inadequate response, loss of response or intolerance to conventional or advanced therapies SAN DIEGO, Dec. 8, 2020 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results